Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Jan 2016;7(1):584-93
a systematic review and meta-analysis
The North America GLP-1 receptor agonist market dominated the revenue with 75.46% share in 2025, supported by a high prevalence of metabolic disorders, early adoption of novel therapeutics, and a well-established healthcare infrastructure
In short, GLP-1 receptor agonists now occupy a leading position among the worlds best-selling medicines , reflecting unprecedented demand for these new diabetes and obesity treatments
US$ 28.40
US$ 29.94
US$ 20.19
US$ 28.49
